Equities
American Ocean Minerals appoints Paul Warmé as CFO
The deep-sea mining firm names an industry veteran to lead its finance team amid expansion plans.
FibroBiologics secures patent for islet transplant method
Biotech firm gains exclusive rights to a novel islet transplantation technique, potentially advancing diabetes treatment.
Acurx secures antibiotic patents in Japan and Mexico
U.S.-based biopharma gains intellectual property protection for two antibiotic candidates in key markets, expanding commercialization potential.
Gujarat Energy reports 63% revenue jump in Q1 FY27 amid rebrand
Revenue rose sharply as the company completed its corporate rebranding initiative, while earnings figures were not disclosed.
Caplin Point Q1 FY27 revenue rises 20% but shares slip on capacity worries
Indian pharma firm posts strong quarterly growth amid investor concerns over production bottlenecks and future scalability.
Autonomix Medical finishes FDA pre-clinical study
Medical technology firm Autonomix Medical has completed a pre-clinical study required for its FDA submission, moving closer to regulatory review.
Savills admits 27.7 million shares after acquisition
UK real estate firm issues additional shares following a strategic acquisition, increasing its share capital.
CoreWeave, Super Micro shares rise on AI infrastructure demand
Shares of AI server providers CoreWeave and Super Micro Computer gain as signs point to sustained investment in artificial intelligence infrastructure.
Sagimet Biosciences shares rise on clinical trial update
Stock climbs after company provides positive interim data from mid-stage trial of lead candidate FASN inhibitor.
Aardvark Therapeutics shares surge on clinical trial update
Biotech stock jumps after positive interim data from an ongoing Phase 2 trial evaluating its lead candidate, AVTX-002.
Joby Aviation to buy Resonant Sciences for $500 million
Deal expands Joby’s eVTOL technology portfolio as it targets commercial air mobility rollout by 2025.
Liberty Media raises $600 mln via convertible notes due 2032
Proceeds to fund general corporate purposes including potential acquisitions or debt refinancing. Notes convertible into Liberty Media shares at a premium.
Spinneys posts Q2 2026 sales growth despite regional instability
Q2 2026 results show mid-single-digit revenue increase as retailer navigates supply chain and geopolitical challenges in core markets.
ADNOC Logistics posts record Q2 profit, raises guidance again
UAE state-linked logistics unit posts record quarterly profit and raises full-year guidance for the third time, citing strong energy sector demand.
Neuronetics shares surge 15% after Q2 earnings beat
Medical device maker posts better-than-expected revenue and profit, lifting shares despite broader sector pressures.
Bosch Q1 FY27 revenue beats forecast as margins rise to 14%
German industrial group Bosch reported first-quarter revenue above analyst expectations and operating margins of 14%, signaling resilient demand despite macroeconomic headwinds.
Pitti Engineering Q1 FY27 results show strong growth, higher capacity use
Automotive component maker Pitti Engineering reported robust quarterly growth and improved plant utilization in Q1 FY27, reflecting strong industry demand.
Amara Raja Q1 FY27 revenue jumps 24% as margins narrow
India’s Amara Raja reports strong quarterly growth driven by volume expansion, though profit margins decline amid rising costs.
Zydus Q1 FY27 revenue rises 22% but margins shrink
Indian drugmaker posts strong top-line growth amid rising cost pressures, with net profit guidance unchanged.
Signet Jewelers names new presidents for Zales, Blue Nile
Company appoints leaders for two key brands as part of leadership restructuring. Changes take effect immediately.
RTL Group says H1 2026 streaming unit profitable, Sky deal finalized
Media group reports first profitable quarter for streaming division while closing acquisition of Sky Deutschland. Shares rise on improved outlook.
Bicara Therapeutics shares rise 3% on trial enrollment progress
Stock gains follow update on pivotal trial enrollment for Bicara Therapeutics' experimental therapy. Shares advance 3% in early trading.
CalciMedica shares rise 6% despite Q2 loss on trial data
Biotech firm posts wider-than-expected loss as pulmonary trial results miss expectations, yet stock climbs on investor optimism.
ECARX shares rise 3% after narrower loss, revenue growth
Chinese automotive tech firm ECARX reports improved quarterly results, with shares climbing 3% as losses shrink and revenue expands.